Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Erika M. Cook"'
Autor:
Simone C. Oostindie, Hilma J. van der Horst, Margaret A. Lindorfer, Erika M. Cook, Jillian C. Tupitza, Clive S. Zent, Richard Burack, Karl R. VanDerMeid, Kristin Strumane, Martine E. D. Chamuleau, Tuna Mutis, Rob N. de Jong, Janine Schuurman, Esther C. W. Breij, Frank J. Beurskens, Paul W. H. I. Parren, Ronald P. Taylor
Publikováno v:
Haematologica, Vol 104, Iss 9 (2019)
CD20 monoclonal antibody therapies have significantly improved the outlook for patients with B-cell malignancies. However, many patients acquire resistance, demonstrating the need for new and improved drugs. We previously demonstrated that the natura
Externí odkaz:
https://doaj.org/article/8951ab20ead14f0a871191432d4962ce
Autor:
Margaret A. Lindorfer, Martine E.D. Chamuleau, Richard Burack, Paul W. H. I. Parren, Clive S. Zent, Ronald P. Taylor, Karl R. VanDerMeid, Tuna Mutis, Rob N. de Jong, Jillian C. Tupitza, Hilma J. van der Horst, Janine Schuurman, Erika M. Cook, Kristin Strumane, Frank J. Beurskens, Esther C.W. Breij, Simone C. Oostindie
Publikováno v:
Haematologica
Haematologica, 104(9), 1841-1852. Ferrata Storti Foundation
Haematologica, 104(9), 1841-1852. FERRATA STORTI FOUNDATION
Oostindie, S C, Van Der Horst, H J, Lindorfer, M A, Cook, E M, Tupitza, J C, Zent, C S, Burack, R, VanDerMeid, K R, Strumane, K, Chamuleau, M E D, Mutis, T, De Jong, R N, Schuurman, J, Breij, E C W, Beurskens, F J, Parren, P W H I & Taylor, R P 2019, ' CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering ', Haematologica, vol. 104, no. 9, pp. 1841-1852 . https://doi.org/10.3324/haematol.2018.207266
Haematologica, 104(9), 1841-1852. Ferrata Storti Foundation
Haematologica, 104(9), 1841-1852. FERRATA STORTI FOUNDATION
Oostindie, S C, Van Der Horst, H J, Lindorfer, M A, Cook, E M, Tupitza, J C, Zent, C S, Burack, R, VanDerMeid, K R, Strumane, K, Chamuleau, M E D, Mutis, T, De Jong, R N, Schuurman, J, Breij, E C W, Beurskens, F J, Parren, P W H I & Taylor, R P 2019, ' CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering ', Haematologica, vol. 104, no. 9, pp. 1841-1852 . https://doi.org/10.3324/haematol.2018.207266
CD20 monoclonal antibody therapies have significantly improved the outlook for patients with B-cell malignancies. However, many patients acquire resistance, demonstrating the need for new and improved drugs. We previously demonstrated that the natura
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43035da1f43e3f084bfdb3c5b9d915b0
https://hdl.handle.net/1887/121519
https://hdl.handle.net/1887/121519
Autor:
Paul W. H. I. Parren, Ronald P. Taylor, Janine Schuurman, Erika M. Cook, Margaret A. Lindorfer, Clive S. Zent, Richard Burack, Hilma J. van der Horst, Frank J. Beurskens, Simone C. Oostindie
Publikováno v:
The Journal of Immunology. 197:1762-1775
Recently, we demonstrated that IgG Abs can organize into ordered hexamers after binding their cognate Ags expressed on cell surfaces. This process is dependent on Fc:Fc interactions, which promote C1q binding, the first step in classical pathway comp
Autor:
Eman L. Dadashian, Nakhle S. Saba, Sivasubramanian Baskar, Erika M. Cook, Hannah R. Robinson, Junpeng Qi, Christoph Rader, Adrian Wiestner, Inhye E. Ahn, Keyvan Keyvanfar, Chingiz Underbayev, Clare Sun, Sarah E. M. Herman, Cydney M. Nichols
The Bruton tyrosine kinase inhibitor ibrutinib induces high rates of clinical response in chronic lymphocytic leukemia (CLL). However, there remains a need for adjunct treatments to deepen response and to overcome drug resistance. Blinatumomab, a CD1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::304a4ea5bb468b219ebdaf51fb194790
https://europepmc.org/articles/PMC6073325/
https://europepmc.org/articles/PMC6073325/
Autor:
Adrian Wiestner, Xiuling Li, Haiyong Peng, Eman L. Dadashian, HaJeung Park, Junpeng Qi, Christoph Rader, Erika M. Cook
T cell-engaging bispecific antibodies (biAbs) present a promising strategy for cancer immunotherapy, and numerous bispecific formats have been developed for retargeting cytolytic T cells toward tumor cells. To explore the therapeutic utility of T cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ee3a46623d68c5a9d4866806086d76c
https://europepmc.org/articles/PMC6004433/
https://europepmc.org/articles/PMC6004433/
Autor:
Burt G van der Boom, Patrick Van Berkel, Patrick J. Engelberts, Paul W. H. I. Parren, Ronald P. Taylor, Marleen Voorhorst, Margaret A. Lindorfer, Rob N. de Jong, Frank J. Beurskens, Ewald T. J. van den Bremer, Erika M. Cook
Publikováno v:
mAbs
mAbs, 7(4), 672-680
van den Bremer, E T J, Beurskens, F J, Voorhorst, M, Engelberts, P J, de Jong, R N, van der Boom, B G, Cook, E M, Lindorfer, M A, Taylor, R P, van Berkel, P H C & Parren, P W H I 2015, ' Human IgG is produced in a pro-form that requires clipping of C-terminal lysines for maximal complement activation ', mAbs, vol. 7, no. 4, pp. 672-680 . https://doi.org/10.1080/19420862.2015.1046665
mAbs, 7(4), 672-680
van den Bremer, E T J, Beurskens, F J, Voorhorst, M, Engelberts, P J, de Jong, R N, van der Boom, B G, Cook, E M, Lindorfer, M A, Taylor, R P, van Berkel, P H C & Parren, P W H I 2015, ' Human IgG is produced in a pro-form that requires clipping of C-terminal lysines for maximal complement activation ', mAbs, vol. 7, no. 4, pp. 672-680 . https://doi.org/10.1080/19420862.2015.1046665
Human IgG is produced with C-terminal lysines that are cleaved off in circulation. The function of this modification was unknown and generally thought not to affect antibody function. We recently reported that efficient C1q binding and complement-dep
Autor:
Miriam Kalbitz, Tim Eiseler, Florian Gebhard, David A. C. Messerer, Holger Barth, Rebecca Wiegner, Stephanie Denk, Manfred Weiss, John D. Lambris, Stephan Paschke, Ronald P. Taylor, Eberhard Barth, Markus Huber-Lang, Tobias Martin, Katharina Pfeiffer, Erika M. Cook, Margaret A. Lindorfer
The complement and neutrophil defence systems, as major components of innate immunity, are activated during inflammation and infection. For neutrophil migration to the inflamed region, we hypothesized that the complement activation product C5a induce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbc97bddaa20246781c22d632270e241
https://europepmc.org/articles/PMC5773343/
https://europepmc.org/articles/PMC5773343/
Autor:
Masashi Mizuno, B. Paul Morgan, Frank J. Beurskens, Richard Burack, Paul W. H. I. Parren, Ronald P. Taylor, Erika M. Cook, Margaret A. Lindorfer, Karl R. VanDerMeid, Clive S. Zent, Janine Schuurman
Publikováno v:
Clinical immunology (Orlando, Fla.). 181
We examined complement-dependent cytotoxicity (CDC) by hexamer formation-enhanced CD20 mAb Hx-7D8 of patient-derived chronic lymphocytic leukemia (CLL) cells that are relatively resistant to CDC. CDC was analyzed in normal human serum (NHS) and serum
Autor:
Edimara S. Reis, Margaret A. Lindorfer, Antonio M. Risitano, John D. Lambris, Ronald P. Taylor, Daniel Ricklin, Erika M. Cook
During malarial anemia, 20 uninfected red blood cells (RBCs) are destroyed for every RBC infected by Plasmodium falciparum (Pf). Increasing evidence indicates an important role for complement in destruction of uninfected RBCs. Products of RBC lysis i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65f58e60bee88c7d1f1d4adc87d4825b
http://hdl.handle.net/11588/657182
http://hdl.handle.net/11588/657182
Autor:
Adrian Wiestner, James P. Dean, Wanlong Ma, Maher Albitar, L. Claire Tsao, Susan Soto, Inhye E. Ahn, Sarah E. M. Herman, Xin Tian, Erika M. Cook, Mei Cheng, David Ipe
Publikováno v:
Blood. 132:186-186
Introduction: We previously reported a prognostic scoring system in CLL using pre-treatment factors in patients treated with ibrutinib [Ahn et al, 2016 ASH Annual Meeting]. Here we present long-term follow-up results and validation of the prognostic